CMI Communications

Breaking down the Desirability of Outcome Ranking (DOOR): unpacking the methodology behind the Dalbavancin as an Option for Treatment of Staphylococcus aureus Bacteremia (DOTS) trial Desirability of Outcome Ranking (DOOR) outcomes such as the primary outcome of the DOTS (Dalbavancin as an Option for Treatment of Staphylococcus aure…

🤔 I’ll admit — I’m still wrapping my head around DOOR in clinical trials. I’m used to P-values and classic non-inferiority, but DOOR feels different.
Breaking down the DOOR in DOTS RCT @cmicomms.bsky.social
#idsky #EMIMCC
www.sciencedirect.com/science/arti...

📣Extra proud of this one:

ESCMID's Trainee Assoc @taescmid.bsky.social reflects on its critical role in peer-reviewing #Communicable podcast episodes:

Our model "sets a precedent for inclusive academic publishing" 😀🎙️
#IDSky #clinmicro #MedEd #MedSky #peerreview

www.cmi-comms.org/article/S295...

Thanks to the authors @kevinsblake.bsky.social, to our peer reviewers, and to @gardp.bsky.social for this important collaboration!
#IDSky #clinmicro #MedSky #AMR

We are very excited to have launched this new collaboration with @gardp.bsky.social! 🚀

This first jointly published commentary on #AMR by @kevinsblake.bsky.social & Gautam Dantas can also be read on our journal page: www.cmi-comms.org/article/S295...

#IDSky #clinmicro

Diagnostic stewardship improves pt care, saves money, & makes doctors' lives easier... what's not to love?

Recording this ep gave me loads of ideas to put into practice...

Breaking down the Desirability of Outcome Ranking (DOOR): unpacking the methodology behind the Dalbavancin as an Option for Treatment of Staphylococcus aureus Bacteremia (DOTS) trial Desirability of Outcome Ranking (DOOR) outcomes such as the primary outcome of the DOTS (Dalbavancin as an Option for Treatment of Staphylococcus aureus Bacteremia) trial can improve statistical effic...

📣 In this first #CLARITY commentary, @seanong.bsky.social & Jonas Tverring @med-jtv.bsky.social examine the #DOTS trial & to help understand the benefits & pitfalls of #DOOR outcomes.
🙏🏼🙏🏼 to them & our peer reviewers!

#IDSky #MedSky #clinmicro #MedEd #methodology

www.cmi-comms.org/article/S295...

📣 We're thrilled to be part of #CLARITY, an initiative led by Josh Davis @gurujosh.bsky.social & @steventong.bsky.social for physicians, pharmacists & #clinmicro specialists passionate about #clinicalresearch & #evidence appraisal.
Join us! 🌱

#IDSky #MedSky #MedEd

www.cmi-comms.org/article/S295...

Communicable E41: Diagnostic stewardship In the last ten years, 'diagnostic stewardship' has emerged as a core...

🎙️ Just published: Communicable E41: Diagnostic s...

Hosted by Angela Huttner @angelahuttner.bsky.social & Annie Joseph @anniejoseph.bsky.social

w/ invited guests Daniel Morgan (USA) & Valerie Vaughn @valerievaughnmd.bsky.social

Listen on #Communicable:

#IDSky #Clinmicro #MedSky #meded

The AMR data repository, supported by Fleming Fund and Wellcome Trust, now covers nearly 70 countries! Apply today to use this data in your research. #GRAM #WAAW
Data: see QR code
Story: bit.ly/4o4oNkz
@bugwonk.bsky.social @wellcometrust.bsky.social @tropicalmedicine.ox.ac.uk @ndm.ox.ac.uk

Carriage of extended-spectrum β-lactamase–producing Enterobacterales among healthy adults: a cohort study in Finland Despite increasing antimicrobial resistance (AMR) in clinical samples in high-income countries, data on healthy community dwellers remains limited. We explored the prevalence and types of extended-spe...

📣 How many healthy people in a high-income, low-resistance country will be #ESBL carriers? In this prospective cohort of >700 adults with no at-risk travel history, whole genome sequencing showed 5% prevalence. It was all #Ecoli.

#IDSky #clinmicro #MedSky #OA

www.cmi-comms.org/article/S295...

📣 New #Communicable drops Mon 1 Dec!
Annie Joseph & Angela Huttner host Dan Morgan (USA) & Valerie Vaughn (USA) to discuss diagnostic stewardship - what it means and why we should do it.

#IDSky #clinmicro #MedSky #meded

Wait, Marc, I've got a screenshot that includes Tara @aetiology.bsky.social (although we're down to half of @germhuntermd.bsky.social, sorry!). Was a great discussion but I hope we didn't pile on @drneilstone.bsky.social too much... Luckily he was tough and gracious at the same time.
#IDSky #MedSky

🌱 New opportunity: We are recruiting a new associate editor for our journal with expertise in viral infections & antiviral therapy. Read our call and apply if you're a good fit! www.cmi-comms.org/article/S295...

⏰ Deadline: 15 Dec 2025

#IDSky #clinmicro #virology #virosky

Communicable E40: AMR in conflict and crisis zones It’s World AMR Awareness Week (WAAW) and we have prepared a special...

🎙️ Just published: Communicable E40: AMR in conflict and crisis zones

Hosted by Nav Narayanan & Thomas Tängdén

w/ invited guests Aula Abbara (UK), Guido Granata (Italy), Tuomas Aro (Finland)

Listen on #Communicable:

#IDSky #Clinmicro #WAAW2025 #AMR @taescmid.bsky.social

📣 New #Communicable drops Mon 17 Nov!
Next week is World AMR Awareness Week #WAAW2025 and we have a special episode. Nav & Thomas invite Aula Abbara (🇬🇧), Guido Granata (🇮🇹) & Tuomas Aro (🇫🇮/ Trainee Association of ESCMID) to discuss the urgent issue of AMR in war & crisis zones.

#IDSky

Carriage of extended-spectrum β-lactamase–producing Enterobacterales among healthy adults: a cohort study in Finland Despite increasing antimicrobial resistance (AMR) in clinical samples in high-income countries, data on healthy community dwellers remains limited. We explored the prevalence and types of extended-spe...

📣 How many healthy people in a high-income, low-resistance country will be #ESBL carriers? In this prospective cohort of >700 adults with no at-risk travel history, whole genome sequencing showed 5% prevalence. It was all #Ecoli.

#IDSky #clinmicro #MedSky #OA

www.cmi-comms.org/article/S295...

Clinical and genomic characterization of Serratia bloodstream infections Previously considered a rare opportunistic pathogen, Serratia is now an emerging cause of bacteraemia. We compared the risk factors and outcomes of patients with Serratia bacteraemia relative to other...

📣 In a US cohort of >2500 #bacteremia patients, #Serratia marcescens was associated with persistent bacteremia and cardiac devices. Yet WGS showed genetic diversity of isolates: infections are not clonal.

#IDSky #clinmicro #MedSky @vancefowler.bsky.social

www.cmi-comms.org/article/S295...

📣The journal is happy to introduce its new fellows joining the editorial board in January!

Congratulations and welcome Laura Jung @laurajng.bsky.social, Rekha Pai Mangalore @rp09.bsky.social, and Victor Dahl @victordahl.bsky.social ✨

#IDSky

📣 NEW: Tara Smith @aetiology.bsky.social replies to our recently published commentary on staying vs leaving Twitter 'Joining the X-odus'

Smith points out "the social cost of harassment and threats on Twitter/X, particularly for women" and more

www.cmi-comms.org/article/S295...

#IDSky #clinmicro

Communicable E39: Dengue on the rise | Communicable | Episode 39 Once confined to the tropics, dengue is spreading via its vector, the Aedes mosquito, to more temperate regions, causing increases in global morbidity, mortality and cost. In 2019, the WHO recognised ...

Better: ☺️

🎙️ Just published: Communicable E39: Dengue on the rise

Hosted by @anniejoseph.bsky.social & Nav Narayanan

w/ invited guests Steven Lim & Andre Siqueira @andre-siqueira.bsky.social

Listen on #Communicable:

#IDSky #Clinmicro #MedSky #dengue #virology

share.transistor.fm/s/48ae30ae

Communicable E39: Dengue on the rise Once confined to the tropics, dengue is spreading via its vector, the...

🎙️ Just published: Communicable E39: Dengue on the rise

Hosted by @angelahuttner.bsky.social & @erinmccreary.bsky.social

w/ invited guests: Barbara Trautner @bwtrautner.bsky.social & Valéry Lavergne

Listen on Communicable:

#IDSky #Clinmicro #MedSky #UTIsky

📣 New #Communicable drops Mon 3 Nov!
@anniejoseph.bsky.social & Nav host @andre-siqueira.bsky.social (Brazil) & Steven Lim (Malaysia) to discuss #dengue as a rising global health burden, how to diagnose & manage it, and what's in the therapeutic pipeline 🔍

@dndi.org #denguealliance #IDSky

Ecological strategies to end the war on resistance

Read about it in my commentary with Gautam Dantas on @gardp.bsky.social and @cmicomms.bsky.social 👉 www.sciencedirect.com/science/arti...

📣In a longitudinal analysis of top ID journals, gender balance is projected for women first authors in 2028 - but for women last authors, only in 2043
The proportion of women editors is projected to remain low

https://www.cmi-comms.org/article/S2950-5909(25)00084-8/

Katharina #IDSky #womeninstem

Interesting - Bluesky definitely a signifixant player in #IDSky community

Comparable share of #IDWeek2025 activity between Bluesky & X reflects recent debate in @cmicomms.bsky.social by @germhuntermd.bsky.social & @drneilstone.bsky.social on merits of 2 platforms
www.cmi-comms.org/article/S295...

Thanks. We're working on that! 😓

📢 Exciting news!

Selected articles from our Antimicrobial Viewpoints series will now be co-published in CMI Communications, @escmid.bsky.social's open-access journal.

This collaboration will expand the reach and amplify the impact of these articles within the antimicrobial R&D community.

Communicable E38: Why do you have to be so complicated? The 2025 IDSA Complicated UTI Guidelines In this episode of Communicable, Erin McCreary and Angela Huttner are...

🎙️ Just published: Communicable E38: Why do you have to be so complicated? The 2025...

Hosted by @angelahuttner.bsky.social & @erinmccreary.bsky.social

w/ invited guests: Barbara Trautner @bwtrautner.bsky.social & Valéry Lavergne

Listen on Communicable:

#IDSky #Clinmicro #MedSky #UTIsky

📣 Is there is value in staying on Twitter/X?

@drneilstone.bsky.social may make you think again even if you did join the #Xodus

& Ilan Schwartz @germhuntermd.bsky.social may make you think again if you didn't

🙏🏼 to both for this thoughtful pro-con

#IDSky #MedSky

www.cmi-comms.org/article/S295...

New pro/con perspective piece by @drneilstone.bsky.social & yours truly

Joining the X-odus: Contrasting perspectives on whether infection specialists should leave X (formerly Twitter)

That I'm sharing it here belies where I stand on the issue

www.cmi-comms.org/article/S295... #IDSky